 | • レポートコード：MRC2-11QY12558 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はリンパ芽球性リンパ腫治療薬のグローバル市場について調査・分析したレポートです。種類別（化学療法、幹細胞移植、標的療法、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別リンパ芽球性リンパ腫治療薬の競争状況、市場シェア ・世界のリンパ芽球性リンパ腫治療薬市場：種類別市場規模 2015年-2020年（化学療法、幹細胞移植、標的療法、その他） ・世界のリンパ芽球性リンパ腫治療薬市場：種類別市場規模予測 2021年-2026年（化学療法、幹細胞移植、標的療法、その他） ・世界のリンパ芽球性リンパ腫治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界のリンパ芽球性リンパ腫治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米のリンパ芽球性リンパ腫治療薬市場分析：米国、カナダ ・ヨーロッパのリンパ芽球性リンパ腫治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのリンパ芽球性リンパ腫治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のリンパ芽球性リンパ腫治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのリンパ芽球性リンパ腫治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Kyowa Kirin、GSK、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection.
Market Analysis and Insights: Global Lymphoblastic Lymphoma Therapeutic Market
The global Lymphoblastic Lymphoma Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lymphoblastic Lymphoma Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lymphoblastic Lymphoma Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lymphoblastic Lymphoma Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lymphoblastic Lymphoma Therapeutic market.
Global Lymphoblastic Lymphoma Therapeutic Scope and Market Size
Lymphoblastic Lymphoma Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lymphoblastic Lymphoma Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Chemotherapy
Stem Cell Transplantation
Targeted Therapy
Others
Market segment by Application, split into
Hospital
Clinic
Other
Based on regional and country-level analysis, the Lymphoblastic Lymphoma Therapeutic market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Lymphoblastic Lymphoma Therapeutic market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Kyowa Kirin
GSK
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lymphoblastic Lymphoma Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Chemotherapy
1.2.3 Stem Cell Transplantation
1.2.4 Targeted Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lymphoblastic Lymphoma Therapeutic Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lymphoblastic Lymphoma Therapeutic Market Perspective (2015-2026)
2.2 Global Lymphoblastic Lymphoma Therapeutic Growth Trends by Regions
2.2.1 Lymphoblastic Lymphoma Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lymphoblastic Lymphoma Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Lymphoblastic Lymphoma Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lymphoblastic Lymphoma Therapeutic Players by Market Size
3.1.1 Global Top Lymphoblastic Lymphoma Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Lymphoblastic Lymphoma Therapeutic Revenue Market Share by Players (2015-2020)
3.2 Global Lymphoblastic Lymphoma Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lymphoblastic Lymphoma Therapeutic Revenue
3.4 Global Lymphoblastic Lymphoma Therapeutic Market Concentration Ratio
3.4.1 Global Lymphoblastic Lymphoma Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lymphoblastic Lymphoma Therapeutic Revenue in 2019
3.5 Key Players Lymphoblastic Lymphoma Therapeutic Area Served
3.6 Key Players Lymphoblastic Lymphoma Therapeutic Product Solution and Service
3.7 Date of Enter into Lymphoblastic Lymphoma Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lymphoblastic Lymphoma Therapeutic Breakdown Data by Type (2015-2026)
4.1 Global Lymphoblastic Lymphoma Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Lymphoblastic Lymphoma Therapeutic Forecasted Market Size by Type (2021-2026)
5 Lymphoblastic Lymphoma Therapeutic Breakdown Data by Application (2015-2026)
5.1 Global Lymphoblastic Lymphoma Therapeutic Historic Market Size by Application (2015-2020)
5.2 Global Lymphoblastic Lymphoma Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lymphoblastic Lymphoma Therapeutic Market Size (2015-2026)
6.2 North America Lymphoblastic Lymphoma Therapeutic Market Size by Type (2015-2020)
6.3 North America Lymphoblastic Lymphoma Therapeutic Market Size by Application (2015-2020)
6.4 North America Lymphoblastic Lymphoma Therapeutic Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Lymphoblastic Lymphoma Therapeutic Market Size (2015-2026)
7.2 Europe Lymphoblastic Lymphoma Therapeutic Market Size by Type (2015-2020)
7.3 Europe Lymphoblastic Lymphoma Therapeutic Market Size by Application (2015-2020)
7.4 Europe Lymphoblastic Lymphoma Therapeutic Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Lymphoblastic Lymphoma Therapeutic Market Size (2015-2026)
8.2 China Lymphoblastic Lymphoma Therapeutic Market Size by Type (2015-2020)
8.3 China Lymphoblastic Lymphoma Therapeutic Market Size by Application (2015-2020)
8.4 China Lymphoblastic Lymphoma Therapeutic Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Lymphoblastic Lymphoma Therapeutic Market Size (2015-2026)
9.2 Japan Lymphoblastic Lymphoma Therapeutic Market Size by Type (2015-2020)
9.3 Japan Lymphoblastic Lymphoma Therapeutic Market Size by Application (2015-2020)
9.4 Japan Lymphoblastic Lymphoma Therapeutic Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Lymphoblastic Lymphoma Therapeutic Market Size (2015-2026)
10.2 Southeast Asia Lymphoblastic Lymphoma Therapeutic Market Size by Type (2015-2020)
10.3 Southeast Asia Lymphoblastic Lymphoma Therapeutic Market Size by Application (2015-2020)
10.4 Southeast Asia Lymphoblastic Lymphoma Therapeutic Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Kyowa Kirin
11.1.1 Kyowa Kirin Company Details
11.1.2 Kyowa Kirin Business Overview
11.1.3 Kyowa Kirin Lymphoblastic Lymphoma Therapeutic Introduction
11.1.4 Kyowa Kirin Revenue in Lymphoblastic Lymphoma Therapeutic Business (2015-2020))
11.1.5 Kyowa Kirin Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Lymphoblastic Lymphoma Therapeutic Introduction
11.2.4 GSK Revenue in Lymphoblastic Lymphoma Therapeutic Business (2015-2020)
11.2.5 GSK Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Lymphoblastic Lymphoma Therapeutic Introduction
11.3.4 Novartis Revenue in Lymphoblastic Lymphoma Therapeutic Business (2015-2020)
11.3.5 Novartis Recent Development
12Analyst’s Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Lymphoblastic Lymphoma Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Stem Cell Transplantation
Table 5. Key Players of Targeted Therapy
Table 6. Key Players of Others
Table 7. Global Lymphoblastic Lymphoma Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Lymphoblastic Lymphoma Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Lymphoblastic Lymphoma Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Lymphoblastic Lymphoma Therapeutic Market Share by Regions (2015-2020)
Table 11. Global Lymphoblastic Lymphoma Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Lymphoblastic Lymphoma Therapeutic Market Share by Regions (2021-2026)
Table 13. Lymphoblastic Lymphoma Therapeutic Market Market Trends
Table 14. Lymphoblastic Lymphoma Therapeutic Market Drivers
Table 15. Lymphoblastic Lymphoma Therapeutic Market Challenges
Table 16. Lymphoblastic Lymphoma Therapeutic Market Restraints
Table 17. Global Lymphoblastic Lymphoma Therapeutic Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Lymphoblastic Lymphoma Therapeutic Market Share by Players (2015-2020)
Table 19. Global Top Lymphoblastic Lymphoma Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lymphoblastic Lymphoma Therapeutic as of 2019)
Table 20. Global Lymphoblastic Lymphoma Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lymphoblastic Lymphoma Therapeutic Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lymphoblastic Lymphoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Lymphoblastic Lymphoma Therapeutic Market Size Share by Type (2015-2020)
Table 26. Global Lymphoblastic Lymphoma Therapeutic Revenue Market Share by Type (2021-2026)
Table 27. Global Lymphoblastic Lymphoma Therapeutic Market Size Share by Application (2015-2020)
Table 28. Global Lymphoblastic Lymphoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Lymphoblastic Lymphoma Therapeutic Market Size Share by Application (2021-2026)
Table 30. North America Lymphoblastic Lymphoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Lymphoblastic Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 32. North America Lymphoblastic Lymphoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Lymphoblastic Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 34. North America Lymphoblastic Lymphoma Therapeutic Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Lymphoblastic Lymphoma Therapeutic Market Share by Country (2015-2020)
Table 36. Europe Lymphoblastic Lymphoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Lymphoblastic Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 38. Europe Lymphoblastic Lymphoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Lymphoblastic Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 40. Europe Lymphoblastic Lymphoma Therapeutic Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Lymphoblastic Lymphoma Therapeutic Market Share by Country (2015-2020)
Table 42. China Lymphoblastic Lymphoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 43. China Lymphoblastic Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 44. China Lymphoblastic Lymphoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 45. China Lymphoblastic Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 46. China Lymphoblastic Lymphoma Therapeutic Market Size by Region (US$ Million) (2015-2020)
Table 47. China Lymphoblastic Lymphoma Therapeutic Market Share by Region (2015-2020)
Table 48. Japan Lymphoblastic Lymphoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Lymphoblastic Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 50. Japan Lymphoblastic Lymphoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Lymphoblastic Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 52. Japan Lymphoblastic Lymphoma Therapeutic Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Lymphoblastic Lymphoma Therapeutic Market Share by Country (2015-2020)
Table 54. Southeast Asia Lymphoblastic Lymphoma Therapeutic Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Lymphoblastic Lymphoma Therapeutic Market Share by Type (2015-2020)
Table 56. Southeast Asia Lymphoblastic Lymphoma Therapeutic Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Lymphoblastic Lymphoma Therapeutic Market Share by Application (2015-2020)
Table 58. Southeast Asia Lymphoblastic Lymphoma Therapeutic Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Lymphoblastic Lymphoma Therapeutic Market Share by Country (2015-2020)
Table 60. Kyowa Kirin Company Details
Table 61. Kyowa Kirin Business Overview
Table 62. Kyowa Kirin Product
Table 63. Kyowa Kirin Revenue in Lymphoblastic Lymphoma Therapeutic Business (2015-2020) (US$ Million)
Table 64. Kyowa Kirin Recent Development
Table 65. GSK Company Details
Table 66. GSK Business Overview
Table 67. GSK Product
Table 68. GSK Revenue in Lymphoblastic Lymphoma Therapeutic Business (2015-2020) (US$ Million)
Table 69. GSK Recent Development
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis Product
Table 73. Novartis Revenue in Lymphoblastic Lymphoma Therapeutic Business (2015-2020) (US$ Million)
Table 74. Novartis Recent Development
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lymphoblastic Lymphoma Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Stem Cell Transplantation Features
Figure 4. Targeted Therapy Features
Figure 5. Others Features
Figure 6. Global Lymphoblastic Lymphoma Therapeutic Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Lymphoblastic Lymphoma Therapeutic Report Years Considered
Figure 11. Global Lymphoblastic Lymphoma Therapeutic Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Lymphoblastic Lymphoma Therapeutic Market Share by Regions: 2020 VS 2026
Figure 13. Global Lymphoblastic Lymphoma Therapeutic Market Share by Regions (2021-2026)
Figure 14. Global Lymphoblastic Lymphoma Therapeutic Market Share by Players in 2019
Figure 15. Global Top Lymphoblastic Lymphoma Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lymphoblastic Lymphoma Therapeutic as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Lymphoblastic Lymphoma Therapeutic Revenue in 2019
Figure 17. North America Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Lymphoblastic Lymphoma Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Kyowa Kirin Revenue Growth Rate in Lymphoblastic Lymphoma Therapeutic Business (2015-2020)
Figure 45. GSK Revenue Growth Rate in Lymphoblastic Lymphoma Therapeutic Business (2015-2020)
Figure 46. Novartis Revenue Growth Rate in Lymphoblastic Lymphoma Therapeutic Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
濾胞性リンパ腫治療の世界市場（～2026年） Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…- 成人T細胞白血病/リンパ腫治療の世界市場（～2026年） Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, an…
- 急性リンパ芽球性白血病薬の世界市場（～2026年） Market Analysis and Insights: Global Acute Lymphoblastic Leukemia Drug Market The global Acute Lymphoblastic Leukemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Acute Lymphoblastic Leukemia Drug Scope and Mar…
- 非ホジキンリンパ腫（NHL）の世界市場（～2026年） Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver. Market An…
- 悪性リンパ腫の世界市場（～2026年） Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have the ability to spread, they are called malignant. The lymphatic system runs throughout our bodies and is composed of lymphoid tissue, vessels, and fluid. Lymphoid tissue contains lymph nodes, which are part…